RecruitingNCT03604133

Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry


Sponsor

QuesGen Systems Inc

Enrollment

500 participants

Start Date

Aug 24, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.


Eligibility

Inclusion Criteria1

  • Physician recommendation to receive the implant in an Ambulatory Surgical Center (ASC)

Exclusion Criteria1

  • N/A

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Cardio Surgical Partners, LLC

Lehi, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03604133


Related Trials